Research I university

DartPoints® to Provide the University of South Carolina with Custom Software-Defined Data Center Solution

Retrieved on: 
Tuesday, July 12, 2022
Information technology, Technology, Public expenditure, Student, Schumacher, University, Architecture, Solution, LinkedIn, CTO, Cockfight, Organization, Government, COVID-19, University of South Carolina, SDDC, Software-defined data center, Division, Twitter, Hospital, Digital divide, Research I university, Efficiency, Partnership, Management, Internet service provider

COLUMBIA, S.C., July 12, 2022 /PRNewswire/ --  DartPoints®, the leading edge digital infrastructure provider, announces today that it has formed an innovative technology partnership with the University of South Carolina. DartPoints will provide a custom Software-Defined Data Center (SDDC) solution, which replaces the university's current data center.

Key Points: 
  • DartPoints will provide a custom Software-Defined Data Center (SDDC) solution, which replaces the university's current data center.
  • DartPoints' custom SDDC cloud solution will significantly improve the university's IT agility.
  • "DartPoints is the ideal partner for our university and its solution is easy to use, highly configurable, and provides the comprehensive services we require."
  • The University of South Carolina is leading the way for cloud-based data centers, as not many universities have fully adopted the model.

Millennium Health and the University of Cincinnati Conducting NIDA-Funded Research Regarding Precipitated Withdrawal During Buprenorphine Induction

Retrieved on: 
Tuesday, May 10, 2022
Mental Health, Health, General Health, Research, Pharmaceutical, Science, Vomiting, Department, Behavioral neuroscience, University, National Institute on Drug Abuse, Illegal drug trade, National Science Foundation, Research I university, Health, Â, Speech disorder, UC, Education, Drug overdose, Buprenorphine, Fentanyl, Opioid use disorder, U.S. News & World Report, Urine, Decision-making, Risk, OUD, Reuters, Anxiety, Pain scale, Carnegie Classification of Institutions of Higher Education, NIDA, Association, Psychiatry, Detergent, News, Chronic pain, Research, Doctor of Pharmacy, University of Cincinnati, Lists of diseases, National Institute, Pharmaceutical industry

Millennium Health , an accredited specialty laboratory specializing in medication monitoring and drug testing, is collaborating with investigators from the University of Cincinnati (UC) to investigate precipitated withdrawal during buprenorphine induction.

Key Points: 
  • Millennium Health , an accredited specialty laboratory specializing in medication monitoring and drug testing, is collaborating with investigators from the University of Cincinnati (UC) to investigate precipitated withdrawal during buprenorphine induction.
  • Funded by a grant from the National Institute on Drug Abuse (NIDA), this research aims to learn more about the extent, regional variation, and frequency of precipitated withdrawal during buprenorphine induction, and to identify factors that increase the likelihood of precipitated withdrawal.
  • The results may inform future treatment approaches, including helping clinicians identify patient risk factors for precipitated withdrawal with buprenorphine induction.
  • Millennium Health recognizes that challenges, including precipitated withdrawal, prevent individuals with OUD from seeking and taking lifesaving medication prescribed for OUD.

Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program By Signing A Collaboration Agreement With The University Of Arizona

Retrieved on: 
Friday, February 25, 2022
GLOBE, Hispanic-serving institution, Research I university, COVID-19, U.S. Securities and Exchange Commission, University of Arizona, Coronavirus, University, News, Growth, SEC, Risk, Pharmacokinetics, Association of American Universities, General Hospital, Entrepreneurship, National Science Foundation, McGill, NASDAQ, U.S. Department of Defense Strategy for Operating in Cyberspace, Immune system, Company, Mouse, Invention, Squamous cell carcinoma, Safety, University of Illinois at Chicago, U.S. News & World Report, Severe acute respiratory syndrome coronavirus 2, Combined small-cell lung carcinoma, Tech, Breast cancer, Student, Pancreatic cancer, Ecosystem, UA, Faculty, Association, CEO, Research, TLA, United States Department of Education, Pharmaceutical industry, MA10

The development of the Companys lead PLpro inhibitor, SBFM-PL4, is currently continuing at the University of Georgia.

Key Points: 
  • The development of the Companys lead PLpro inhibitor, SBFM-PL4, is currently continuing at the University of Georgia.
  • We are delighted to be working with the University of Arizona Coronavirus research team led by Dr. Gregory Thatcher as well as the commercialization team at Tech Launch Arizona, said Dr. Steve Slilaty, CEO of Sunshine Biopharma.
  • Tech Launch Arizona is the office of the University of Arizona that creates social and economic impact through commercializing inventions stemming from university research.
  • In addition, to working on the development of a treatment for COVID-19, Sunshine Biopharma is engaged in the development Adva-27a, a unique anticancer compound.

Humana, the Humana Foundation and UofL Announce up to $25 Million Investment in Health Equity Innovation Hub

Retrieved on: 
Wednesday, February 16, 2022
Research, Managed Care, Professional Services, Philanthropy, University, Education, Foundation, Science, Insurance, Human Resources, Practice Management, Health, History, Health, NYSE, University of Louisville School of Medicine, Medicare, Patient, Atlantic Coast Conference, Quality of life, Foundation, Health equity, School, Research, Classification, Carnegie Classification of Institutions of Higher Education, Achievement, Mentorship, Engineering, Solution, Innovation, The Hub, Goal, Leadership, Carnegie, Inc., Student, Executive director, Grand Challenges, Research I university, Culture, Hub, Population, UofL, Public health, Faculty, Physician, Senior, Entrepreneurship, Corporate social responsibility, Conference, University, Education, Creative industries, Management, Renewable energy, Medicine, Humana

The Hub is funded by a potential total investment of $25 million, including $10 million from UofL, $1.5 million from Humana and up to $13.5 million from The Humana Foundation.

Key Points: 
  • The Hub is funded by a potential total investment of $25 million, including $10 million from UofL, $1.5 million from Humana and up to $13.5 million from The Humana Foundation.
  • The Health Equity Innovation Hub is an integrated, multi-disciplinary collaboration among Humana, The Humana Foundation and UofL.
  • Enabled by Humana and The Humana Foundations investment and support, the Hub will seek to develop solutions for health inequities in Louisville and globally.
  • We are proud to work with Humana and The Humana Foundation to further health equity for all through this new Hub.

Old Dominion University Earns Prestigious Research 1 Designation from Carnegie Classification of Institutions of Higher Education

Retrieved on: 
Tuesday, December 21, 2021
Carnegie Classification of Institutions of Higher Education, Indiana University, Center, Program, National Ocean Service, Classification, ODU, University, U.S. News & World Report, JLab, Langley Research Center, Department of Defense Serum Repository, NASA, Thomas Jefferson National Accelerator Facility, Carnegie Commission on Educational Television, Industry, Review, Faculty, Wallops Flight Facility, Policy, Old Dominion University, Student, Education, Workforce, Department, Albion College, Comment, Research, Carnegie, GLOBE, Research I university, News, Medical device, Medicine, Management

NORFOLK, VA, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Old Dominion University earned the Research 1 Classification, indicating very high research activity, from the Carnegie Classification of Institutions of Higher Education, placing it among the highest level of research institutions in the United States.

Key Points: 
  • NORFOLK, VA, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Old Dominion University earned the Research 1 Classification, indicating very high research activity, from the Carnegie Classification of Institutions of Higher Education, placing it among the highest level of research institutions in the United States.
  • The Carnegie Classification has been the leading measure of research activities at U.S. colleges and institutions for more than half a century.
  • The University joins a group of just 137, or 5%, of four-year research institutions with the R1 classification in the nation.
  • The Carnegie Commission on Higher Education developed the Carnegie Classification in 1970 to support its program of research and policy analysis.

University of Denver Joins List of Highest Level of Research Institutions in the United States

Retrieved on: 
Monday, December 20, 2021
Twitter, Classification, Rocky Mountains, University, Organization, Learning, Student, DU, Education, University of Denver, Carnegie Classification of Institutions of Higher Education, Research I university, Dream, Research, Multimedia, View, Faculty, Knowledge, Facebook, Management, Medicine

DENVER, Dec. 20, 2021 /PRNewswire/ -- The University of Denver (DU) has joined a prestigious list of universities to now be classified as one of the top research institutions in the country.

Key Points: 
  • DENVER, Dec. 20, 2021 /PRNewswire/ -- The University of Denver (DU) has joined a prestigious list of universities to now be classified as one of the top research institutions in the country.
  • DU is the fourth university in Colorado and the only private institution in the Rocky Mountain Region to achieve Research 1 (R1) classification.
  • DU Joins 136 prestigious institutions of higher education classified as R1 universities in the United States.
  • The University of Denver is one of only nine universities to join the list of the highest level of research institutions in 2021.